Mesoblast Limited
MESO stock score: 52/100
$15.67 · +17.03% · Scored Oct 29, 2026
- Technical
- 61
- Fundamental
- 42
- News
- —
The reading
Mesoblast (MESO) scores 52 out of 100, which reads neutral, higher than 64% of Healthcare stocks and 45% of the 4,158 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 61, fundamentals 42.
Among the fundamentals, Price Target at 100 and Revenue Growth (Annual) at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 69 and contrarian oscillators 42 — a split worth reading before trusting the technical total.
Since Aug 1, 2026 the composite has ranged from 37 to 64, and it is down 12 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward MESO’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
42Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Revenue Growth (Annual)100
Annual revenue growth tracks year-over-year sales expansion.
- Institutional Ownership100
Institutional ownership measures the percentage held by professional investors.
Holding it back
- Earnings Profitability (Quarterly)0
Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.
- Earnings Quality (Annual)0
Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
37 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical · daily
64Pulling it up
- EMA 5100
Exponential Moving Average (5-period) gives more weight to recent prices, making it more responsive to new information than simple moving averages.
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- SMA 5100
Simple Moving Average (5-period) tracks the average price over the last 5 periods.
Holding it back
- Bollinger Bands (20)0
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
- TRIX6
TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.
- Williams %R (7)11
Williams %R (7-period) places the close within the last 7 periods' high-low range.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 59 | 1 |
| Daily | 64 | 3 |
| Weekly | 62 | 2 |
| Monthly | 55 | 2 |
| Quarterly | 64 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 30, 2026 | 52 |
| Oct 29, 2026 | 43 |
| Oct 28, 2026 | 42 |
| Oct 27, 2026 | 39 |
| Oct 26, 2026 | 38 |
| Oct 25, 2026 | 38 |
| Oct 24, 2026 | 38 |
| Oct 23, 2026 | 39 |
| Oct 22, 2026 | 40 |
| Oct 21, 2026 | 38 |
| Oct 20, 2026 | 37 |
| Oct 19, 2026 | 39 |
| Oct 18, 2026 | 39 |
| Oct 17, 2026 | 40 |
| Oct 16, 2026 | 41 |
| Oct 15, 2026 | 41 |
| Oct 14, 2026 | 41 |
| Oct 13, 2026 | 43 |
| Oct 12, 2026 | 43 |
| Oct 11, 2026 | 43 |
| Oct 10, 2026 | 43 |
| Oct 9, 2026 | 41 |
| Oct 8, 2026 | 41 |
| Oct 7, 2026 | 40 |
| Oct 6, 2026 | 42 |
| Oct 5, 2026 | 41 |
| Oct 4, 2026 | 41 |
| Oct 3, 2026 | 41 |
| Oct 2, 2026 | 41 |
| Oct 1, 2026 | 42 |
| Sep 30, 2026 | 43 |
| Sep 29, 2026 | 42 |
| Sep 28, 2026 | 44 |
| Sep 26, 2026 | 44 |
| Sep 25, 2026 | 48 |
| Sep 24, 2026 | 47 |
| Sep 23, 2026 | 49 |
| Sep 22, 2026 | 46 |
| Sep 21, 2026 | 44 |
| Sep 20, 2026 | 44 |
| Sep 19, 2026 | 45 |
| Sep 18, 2026 | 44 |
| Sep 17, 2026 | 42 |
| Sep 16, 2026 | 43 |
| Sep 15, 2026 | 44 |
| Sep 14, 2026 | 45 |
| Sep 13, 2026 | 45 |
| Sep 12, 2026 | 45 |
| Sep 11, 2026 | 45 |
| Sep 10, 2026 | 48 |
| Sep 9, 2026 | 50 |
| Sep 8, 2026 | 52 |
| Sep 7, 2026 | 52 |
| Sep 6, 2026 | 52 |
| Sep 5, 2026 | 52 |
| Sep 4, 2026 | 52 |
| Sep 3, 2026 | 51 |
| Sep 2, 2026 | 50 |
| Sep 1, 2026 | 49 |
| Aug 31, 2026 | 51 |
| Aug 30, 2026 | 51 |
| Aug 29, 2026 | 51 |
| Aug 28, 2026 | 50 |
| Aug 27, 2026 | 49 |
| Aug 26, 2026 | 49 |
| Aug 25, 2026 | 48 |
| Aug 24, 2026 | 49 |
| Aug 20, 2026 | 50 |
| Aug 19, 2026 | 50 |
| Aug 18, 2026 | 50 |
| Aug 17, 2026 | 47 |
| Aug 16, 2026 | 46 |
| Aug 15, 2026 | 46 |
| Aug 14, 2026 | 49 |
| Aug 13, 2026 | 49 |
| Aug 12, 2026 | 50 |
| Aug 11, 2026 | 50 |
| Aug 10, 2026 | 48 |
| Aug 9, 2026 | 48 |
| Aug 8, 2026 | 48 |
| Aug 7, 2026 | 49 |
| Aug 4, 2026 | 45 |
| Aug 1, 2026 | 64 |
Key facts
- Market cap
- $2.0B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 0.86
- Risk grade (1–10)
- —
- Next earnings
- Aug 26, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| IMNM Immunome | $2.2B | 41 |
| SEPN Septerna | $2.1B | 60 |
| ABSI Absci | $2.1B | 46 |
| ZYME Zymeworks | $2.1B | 52 |
| SLS SELLAS Life Sciences Group | $2.1B | 45 |
| SRPT Sarepta Therapeutics | $2.0B | 39 |
Questions
What is MESO's stock score today?
MESO scores 52/100 (Neutral) as of Oct 29, 2026: technical 61, fundamental 42. Scores are recomputed every night.
Is MESO a buy?
The score is not a buy or sell recommendation. A 52 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the MESO score calculated?
98 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.